Taro Pharmaceutical Industries Ltd. announced that the company has received a warning letter on February 5, 2009 from the US Food and Drug Administration (FDA) regarding the inspection of the company's Canadian manufacturing facility in July 2008.
The details can be read here.
No comments:
Post a Comment